Rejuvenation Research is an authoritative peer-reviewed journal that publishes leading work on the implementation of rejuvenation therapies in the laboratory and eventually in the clinic, as well as basic research relevant to the further elucidation of what such therapies must do at the molecular and cellular level in order to be truly effective. Sociopolitical and ethical issues relating to substantial extension of healthy human life expectancy are also covered. RR is a relaunch of the Journal of Anti-Aging Medicine, coinciding with my taking over as Editor-in-Chief from Michael Fossel.

A fuller description of the aims and scope of RR is contained in the editorial to the first issue, which I thank the publishers, Mary Ann Liebert, Inc. of New York, for allowing me to post.

Rejuvenation Research is indexed in PubMed, Current Contents/Clinical Medicine and all key indexing services. Perhaps the best measure of the quality of academic rigour and value that RR promises to provide is its editorial board, which includes world leaders in all relevant areas of biology and its social context, including stem cell therapy, tissue engineering, gene therapy, public policy, cancer therapies, demography and more.

Manuscripts may be submitted for publication via the journal website; please take care to ensure that they conform to the instructions for authors.

Tables of contents are available here.